The Effect of Using Different Scaffolds in Retreated Teeth on The Clinical and Radiological Success of Regenerative Endodontic Treatment
This clinical study aims to compare the clinical and radiographic outcomes of four different scaffolds used in regenerative endodontic treatment of previously root canal-treated permanent teeth requiring retreatment.
Participants will be randomly assigned to one of four groups based on the scaffold used: induced blood clot, injectable platelet-rich fibrin (i-PRF), advanced platelet-rich fibrin (A-PRF), or advanced platelet-rich fibrin plus (A-PRF+). All participants will receive the same root canal disinfection and restorative procedures, with the scaffold type differing between the groups.
Participants will be evaluated clinically and radiographically at 3, 6, and 12 months after treatment. The study will compare the groups in terms of the resolution of clinical signs and symptoms and changes observed on radiographic and cone-beam computed tomography images.
Tutkimuksen yleiskatsaus
Tila
Yksityiskohtainen kuvaus
This study was designed as a prospective, controlled clinical trial to compare the clinical and radiographic outcomes of four regenerative endodontic approaches applied to permanent teeth requiring single-root retreatment. The sample size was calculated using G*Power v3.1 (Heinrich Heine University, Düsseldorf, Germany) based on an effect size of 0.50, a significance level of 0.05, and a power of 0.80; a total of 60 patients, with 15 patients per group, were planned to be included in the study. The null hypothesis (H0) of this study is that there will be no difference in the clinical and radiographic success of four different regenerative approaches (apically induced blood clot, injected i-PRF, A-PRF, and A-PRF+) applied to necrotic permanent teeth requiring single-root retreatment. The necessary institutional approval and ethics committee approval have been obtained for this study. Patient participation will be voluntary; patients will be informed about the study, and informed consent forms will be obtained from those who wish to participate. Following the application of local anesthesia and a rubber dam, the relevant teeth will be disinfected with 2.5% NaOCl, and the general shape of the cavity will be formed using a sterile diamond bur with a high-speed, water-cooled air turbine. If caries is present, sterile steel burs attached to a low-speed micromotor and an angle piece will be used to remove it. Once the access cavity is complete, the root canal filling material will be removed with retreatment files without chemical agents. The working length will be determined, and mechanical preparation will be kept to a minimum. The apical opening will be enlarged to a diameter equal to the tip diameter of a #40 file. For root canal irrigation, 20 mL of 1.5% sodium hypochlorite, 20 mL of normal saline, and 10 mL of 17% EDTA will be used. After calcium hydroxide is placed in the root canal, the tooth will be sealed with a temporary filling material. Second Session (3 weeks later): If there are no symptoms, the temporary filling material and calcium hydroxide will be removed. A final irrigation will be performed with 20 mL of 17% EDTA. The volunteer patients included in the study will be divided into four groups according to the random assignment determined on the www.randomizer.org website.
Group 1: (Blood Clot Group) Bleeding will be induced by exiting the apical foramen with sterile Type K files to ensure the canal is filled with blood.
Group 2: (i-PRF Group) 10 cc of venous blood drawn from the patient's antecubital vein will be centrifuged at 700 rpm for 3 minutes. The upper yellow layer will be drawn up with a syringe and injected into the root canal.
Group 3: (A-PRF group) The 10 cc of venous blood obtained as in Group 2 will be centrifuged at 1500 rpm for 14 minutes. The upper yellow layer will be removed from the tube and applied to the root canal using sterile pluggers.
Group 4: (A-PRF+ group) The 10 cc of venous blood obtained as in Group 2 will be centrifuged at 1300 rpm for 8 minutes. The yellow layer on top will be removed from the tube and applied to the canal using sterile applicators.
In all groups, after a bioceramic-based covering material is placed over the scaffold, a glass ionomer base material will be applied, and the teeth will be restored with a bonding agent and composite. Post-treatment, periapical X-rays will be taken of all patients, and a KIBT scan will be performed. Patients will be evaluated clinically and radiographically at 3-, 6-, and 12-month follow-up visits. The clinical evaluation will assess spontaneous pain, percussion sensitivity, palpation sensitivity, the presence of a fistula, and mobility. Vitality tests will be performed using a cold test and an electrical pulp test. At the 12-month follow-up, a KIBT scan will be performed to examine changes in lesion size, root wall thickness, or hard tissue formation.
Measurement of Dentin Thickness KIBT images will be acquired using an I-CAT (Imaging Sciences, Hatfield, PA, USA) tomography device in accordance with the standard imaging protocol. During imaging, the Frankfurt horizontal plane will be positioned parallel to the floor. In contrast, the midsagittal plane will be positioned perpendicular to the floor using the jaw support unit and laser alignment beams. Images will be acquired using standard parameters: an 8x8 cm field of view (FOV) of the relevant jaw, 120 kVp, 8 mA, a voxel size of 0.25 mm³, and a scan time of 14.7 seconds. Dentin thickness measurements for the relevant tooth will be performed on axial sections. Measurements will be determined in millimeters at three regions-4, 6, and 8 mm from the radiographic apex-based on the distance between the root canal wall and the external root surface.
Root Canal Volume Measurement Root canal volume measurements for the teeth will be performed using the ITK-SNAP software. KIBT images will be imported into the program in DICOM format. The region of interest will be delineated as a rectangular area using a semi-automatic segmentation method. During segmentation of all images, the minimum and maximum threshold values will be optimized based on the gray density distribution. Minimal manual adjustments will be made for each tooth as necessary. A region-growing algorithm will be applied, and a manual spread point will be placed at the root canal midpoint. The segmentation process will spread outward from the selected spread point and automatically terminate when it exceeds the predefined threshold boundaries. Segmentation areas extending beyond the anatomical boundaries will be manually corrected. The resulting volume values will be recorded in mm³ via the software's "Volume and Statistics" tab.
Measurement of Periapical Lesion Dimensions Periapical lesion dimensions will be assessed in millimeters along three axes. The bucco-lingual and mesio-distal widths of the lesion will be measured on the axial section where the lesion appears widest. The vertical dimension will be determined from the sagittal section at which the lesion appears widest.
Statistical Analysis All data will be analyzed using SPSS Statistics 17.0 for Windows (SPSS Inc., Chicago, IL), and a P-value of < 0.05 will be considered statistically significant. Lesion size and dentin thickness will be analyzed using a t-test. Volumetric changes in the root canal before and after regenerative endodontic treatment will be tested using the Wilcoxon signed-rank test.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: ALİ ERDEMİR, Professor
- Puhelinnumero: +905325650065
- Sähköposti: erdemirali@hotmail.com
Tutki yhteystietojen varmuuskopiointi
- Nimi: Sara NAJJARİ HAGH
- Puhelinnumero: +905525981520
- Sähköposti: saranajjari1998@gmail.com
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Lapsi
- Aikuinen
Hyväksyy terveitä vapaaehtoisia
Näytteenottomenetelmä
Tutkimusväestö
Kuvaus
Inclusion Criteria:
- Patients aged 16-40 who are systemically healthy
- Patients who have a permanent tooth with a single root canal and fully developed root that requires retreatment
- Patients who may or may not have periapical radiolucency
Exclusion Criteria:
- Patients who require antibiotic prophylaxis
- Patients with systemic conditions such as diabetes or hematological disorders
- Patients who have taken antibiotics, anti-inflammatory medications, and/or antidepressants within the past three weeks
- Patients who are pregnant or suspect they may be pregnant during treatment
- Patients with heavy plaque and tartar buildup on their teeth
- Patients with redness and bleeding of the gums
- Patients with severe gingivitis, generalized periodontitis, or a periodontal pocket depth of more than 3 mm
- Patients with internal or external root resorption
- Patients for whom complete isolation with a rubber dam cannot be achieved
- Patients with an open, immature root apex
- Patients with horizontal or vertical fractures
- Patients with teeth having multiple roots or root canals
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
Kohortit ja interventiot
Ryhmä/Kohortti |
|---|
|
Blood clot group
Bleeding will be induced by removing the apical opening with sterile Type K files to ensure the canal fills with blood.
The blood clot induced apically will be used as the scaffold material.
|
|
i-PRF group
10 cc of venous blood drawn from the patient's antecubital vein will be centrifuged at 700 rpm for 3 minutes.
The yellow layer on top will be drawn up with a syringe and injected into the canal.
i-PRF will be used as the scaffold material.
|
|
A-PRF group
The 10 cc of venous blood obtained as in Group 2 will be centrifuged at 1500 rpm for 14 minutes.
The yellow layer on top will be removed from the tube and applied into the canal using sterile applicators.
A-PRF will be used as the scaffold material.
|
|
A-PRF+ group
As in Group 2, 10 cc of venous blood will be centrifuged at 1300 rpm for 8 minutes.
The yellow layer on top will be removed from the tube and applied into the canal using sterile pluggers.
A-PRF+ will be used as the scaffold material.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Proportion of Teeth Achieving Clinical and Radiographic Success at 12 Months
Aikaikkuna: 12 months after treatment
|
Clinical and radiographic success will be assessed as a composite binary outcome for each treated tooth at the 12-month follow-up.
A tooth will be classified as successful if both clinical and radiographic success criteria are met.
Clinical success will be defined as the absence of spontaneous pain, tenderness to percussion, tenderness to palpation, swelling, sinus tract, and pathological mobility.
Radiographic success will be defined as reduction or complete resolution of the baseline periapical lesion without the development of a new periapical lesion.
The outcome will be reported as the proportion of teeth achieving clinical and radiographic success at 12 months.
|
12 months after treatment
|
Toissijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
CBCT-Based Change in Aggregate Periapical Lesion Size From Baseline to 12 Months
Aikaikkuna: From baseline to 12 months after treatment
|
Periapical lesion size will be assessed on cone-beam computed tomography images at baseline and at the 12-month follow-up.
The mesiodistal, buccolingual, and vertical dimensions of the lesion will be measured in millimeters.
These three linear measurements will be summed to obtain one aggregate periapical lesion size value for each tooth.
The change in aggregate periapical lesion size from baseline to 12 months will be compared among the scaffold groups.
|
From baseline to 12 months after treatment
|
|
CBCT-Based Change in Mean Dentinal Wall Thickness From Baseline to 12 Months
Aikaikkuna: From baseline to 12 months after treatment
|
Dentinal wall thickness will be measured in millimeters on cone-beam computed tomography images at baseline and at the 12-month follow-up.
Measurements will be performed at predefined levels from the radiographic apex, and the mean of these measurements will be calculated to obtain one dentinal wall thickness value for each tooth.
The change in mean dentinal wall thickness from baseline to 12 months will be compared among the scaffold groups.
|
From baseline to 12 months after treatment
|
|
CBCT-Based Change in Root Canal Volume From Baseline to 12 Months
Aikaikkuna: From baseline to 12 months after treatment
|
Root canal volume will be measured in cubic millimeters on cone-beam computed tomography images at baseline and at the 12-month follow-up using image analysis software.
The change in root canal volume from baseline to 12 months will be compared among the scaffold groups.
|
From baseline to 12 months after treatment
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Arvioitu)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Muut tutkimustunnusnumerot
- 2026/08-2026.06.25
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .